FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155202277> ?p ?o ?g. }

• W2155202277 abstract "For patients with rheumatoid arthritis (RA) whose treatment with a tumour necrosis factor inhibitor (TNFi) is failing, several biological treatment options are available. Often, another TNFi or a biological with another mode of action is prescribed. The objective of this study was to compare the effectiveness and cost-effectiveness of three biologic treatments with different modes of action in patients with RA whose TNFi therapy is failing.We conducted a pragmatic, 1-year randomised trial in a multicentre setting. Patients with active RA despite previous TNFi treatment were randomised to receive abatacept, rituximab or a different TNFi. The primary outcome (Disease Activity Score in 28 joints) and the secondary outcomes (Health Assessment Questionnaire Disability Index and 36-item Short Form Health Survey scores) were analysed using linear mixed models. Cost-effectiveness was analysed on the basis of incremental net monetary benefit, which was based on quality-adjusted life-years (calculated using EQ-5D scores), and all medication expenditures consumed in 1 year. All analyses were also corrected for possible confounders.Of 144 randomised patients, 5 were excluded and 139 started taking abatacept (43 patients), rituximab (46 patients) or a different TNFi (50 patients). There were no significant differences between the three groups with respect to multiple measures of RA outcomes. However, our analysis revealed that rituximab therapy is significantly more cost-effective than both abatacept and TNFi over a willingness-to-pay range of 0 to 80,000 euros.All three treatment options were similarly effective; however, when costs were factored into the treatment decision, rituximab was the best option available to patients whose first TNFi treatment failed. However, generalization of these costs to other countries should be undertaken carefully.Netherlands Trial Register number NTR1605. Registered 24 December 2008." @default.
• W2155202277 created "2016-06-24" @default.
• W2155202277 creator A5005994370 @default.
• W2155202277 creator A5006123817 @default.
• W2155202277 creator A5008395067 @default.
• W2155202277 creator A5012743754 @default.
• W2155202277 creator A5023478522 @default.
• W2155202277 creator A5030944374 @default.
• W2155202277 creator A5044485746 @default.
• W2155202277 creator A5058501685 @default.
• W2155202277 creator A5063064800 @default.
• W2155202277 creator A5064928139 @default.
• W2155202277 creator A5070768773 @default.
• W2155202277 creator A5073922172 @default.
• W2155202277 creator A5076651742 @default.
• W2155202277 creator A5082337435 @default.
• W2155202277 creator A5091151755 @default.
• W2155202277 date "2015-05-22" @default.
• W2155202277 modified "2023-10-18" @default.
• W2155202277 title "Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial" @default.
• W2155202277 cites W1499640956 @default.
• W2155202277 cites W1840538016 @default.
• W2155202277 cites W196138004 @default.
• W2155202277 cites W1965926642 @default.
• W2155202277 cites W1969355584 @default.
• W2155202277 cites W1990524824 @default.
• W2155202277 cites W2000139274 @default.
• W2155202277 cites W2000905503 @default.
• W2155202277 cites W2005885148 @default.
• W2155202277 cites W2024644107 @default.
• W2155202277 cites W2024651299 @default.
• W2155202277 cites W2037377025 @default.
• W2155202277 cites W2040509878 @default.
• W2155202277 cites W2053692867 @default.
• W2155202277 cites W2064133813 @default.
• W2155202277 cites W2087046046 @default.
• W2155202277 cites W2097553517 @default.
• W2155202277 cites W2102987799 @default.
• W2155202277 cites W2105226906 @default.
• W2155202277 cites W2108519284 @default.
• W2155202277 cites W2110177517 @default.
• W2155202277 cites W2112966993 @default.
• W2155202277 cites W2113018560 @default.
• W2155202277 cites W2113131907 @default.
• W2155202277 cites W2119723369 @default.
• W2155202277 cites W2122389877 @default.
• W2155202277 cites W2122717603 @default.
• W2155202277 cites W2125794399 @default.
• W2155202277 cites W2128600935 @default.
• W2155202277 cites W2132841358 @default.
• W2155202277 cites W2133028044 @default.
• W2155202277 cites W2134083368 @default.
• W2155202277 cites W2134704116 @default.
• W2155202277 cites W2136215457 @default.
• W2155202277 cites W2148692760 @default.
• W2155202277 cites W2149223963 @default.
• W2155202277 cites W2152619496 @default.
• W2155202277 cites W2153836018 @default.
• W2155202277 cites W2157770246 @default.
• W2155202277 cites W2161880026 @default.
• W2155202277 cites W2167061160 @default.
• W2155202277 cites W2341953096 @default.
• W2155202277 cites W2473786944 @default.
• W2155202277 cites W4292806894 @default.
• W2155202277 cites W45832520 @default.
• W2155202277 doi "https://doi.org/10.1186/s13075-015-0630-5" @default.
• W2155202277 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4489004" @default.
• W2155202277 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25997746" @default.
• W2155202277 hasPublicationYear "2015" @default.
• W2155202277 type Work @default.
• W2155202277 sameAs 2155202277 @default.
• W2155202277 citedByCount "53" @default.
• W2155202277 countsByYear W21552022772015 @default.
• W2155202277 countsByYear W21552022772016 @default.
• W2155202277 countsByYear W21552022772017 @default.
• W2155202277 countsByYear W21552022772018 @default.
• W2155202277 countsByYear W21552022772019 @default.
• W2155202277 countsByYear W21552022772020 @default.
• W2155202277 countsByYear W21552022772021 @default.
• W2155202277 countsByYear W21552022772022 @default.
• W2155202277 countsByYear W21552022772023 @default.
• W2155202277 crossrefType "journal-article" @default.
• W2155202277 hasAuthorship W2155202277A5005994370 @default.
• W2155202277 hasAuthorship W2155202277A5006123817 @default.
• W2155202277 hasAuthorship W2155202277A5008395067 @default.
• W2155202277 hasAuthorship W2155202277A5012743754 @default.
• W2155202277 hasAuthorship W2155202277A5023478522 @default.
• W2155202277 hasAuthorship W2155202277A5030944374 @default.
• W2155202277 hasAuthorship W2155202277A5044485746 @default.
• W2155202277 hasAuthorship W2155202277A5058501685 @default.
• W2155202277 hasAuthorship W2155202277A5063064800 @default.
• W2155202277 hasAuthorship W2155202277A5064928139 @default.
• W2155202277 hasAuthorship W2155202277A5070768773 @default.
• W2155202277 hasAuthorship W2155202277A5073922172 @default.
• W2155202277 hasAuthorship W2155202277A5076651742 @default.
• W2155202277 hasAuthorship W2155202277A5082337435 @default.
• W2155202277 hasAuthorship W2155202277A5091151755 @default.
• W2155202277 hasBestOaLocation W21552022771 @default.
• W2155202277 hasConcept C112930515 @default.
• W2155202277 hasConcept C126322002 @default.

• next